Biogened Temettü
Temettü kriter kontrolleri 2/6
Biogened is a dividend paying company with a current yield of 2.14% that is well covered by earnings. Next payment date is on 18th November, 2024 with an ex-dividend date of 12th September, 2024.
Anahtar bilgiler
2.1%
Temettü verimi
n/a
Geri Alım Getirisi
| Toplam Hissedar Getirisi | n/a |
| Gelecekteki Temettü Verimi | n/a |
| Temettü Büyümesi | n/a |
| Bir sonraki temettü ödeme tarihi | 18 Nov 24 |
| Eski temettü tarihi | 12 Sep 24 |
| Hisse başına temettü | zł0.500 |
| Ödeme oranı | 23% |
Son temettü güncellemeleri
Recent updates
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb
Aug 28
Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)
Aug 22Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding
May 23Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden
May 09Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations
Feb 21Is Biogened (WSE:BGD) A Risky Investment?
Feb 01Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump
Feb 01We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt
Jun 30Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly
Oct 08Is Biogened (WSE:BGD) A Risky Investment?
Jun 29Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?
Mar 25These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well
Dec 09Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet
Jul 29Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly
Apr 30Is Biogened (WSE:BGD) A Risky Investment?
Jan 24Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Whilst dividend payments have been stable, BGD has been paying a dividend for less than 10 years.
Büyüyen Temettü: BGD's dividend payments have increased, but the company has only paid a dividend for 3 years.
Piyasaya Karşı Temettü Getirisi
| Biogened Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (BGD) | 2.1% |
| Pazarın Alt %25'i (PL) | 2.8% |
| Pazarın En İyi %25'i (PL) | 8.0% |
| Sektör Ortalaması (Pharmaceuticals) | 2.4% |
| Analist tahmini (BGD) (3 yıla kadar) | n/a |
Önemli Temettü: BGD's dividend (2.14%) isn’t notable compared to the bottom 25% of dividend payers in the Polish market (2.82%).
Yüksek Temettü: BGD's dividend (2.14%) is low compared to the top 25% of dividend payers in the Polish market (7.96%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its low payout ratio (22.9%), BGD's dividend payments are well covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: With its reasonably low cash payout ratio (30.1%), BGD's dividend payments are well covered by cash flows.